Inflammatory Macrophage-Targeted Atherosclerosis Treatment by miRNA-Delivered, MRI-Visible, and Anti-Inflammatory Nanomedicine
- 28 May 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (22) , 20472-20490
Abstract
Atherosclerosis, a principal cause of fatal cardiovascular diseases, is fundamentally a chronic inflammatory disease. Addressing this, the combined regulation of oxidative stress and inflammation through synergistic modalities offers an efficient therapeutic avenue. In this work, we rationally designed and engineered a highly efficient functional nanosystem, referred to as polydopamine nanoparticles doped with arginine and gadolinium ions (AGPDAR-146a), for the targeted delivery of therapeutic oligonucleotides, specifically microRNA-146a (miR-146a), to inflammatory macrophages within atherosclerotic plaques. AGPDAR-146a nanoparticles effectively load and deliver miR-146a, achieving enhanced accumulation in inflammatory macrophages through the specific interaction between miR-146a and class A scavenger receptors. Functionally, AGPDAR-146a nanoparticles excel in eliminating reactive oxygen species and exert anti-inflammatory effects, principally by modulating the nuclear factor kappa-light-chain-enhancer of activated B cells pathway and the interferon regulatory factor 5 protein, consequently helping to reduce and stabilize atherosclerotic plaques. Additionally, the intrinsic T1 magnetic resonance imaging capability of AGPDAR-146a nanoparticles enables real-time visualization of the progression of plaque inflammation. Therefore, the engineered nanosystem not only underscores the therapeutic potential of miR-146a in atherosclerosis but also illustrates a versatile microRNA delivery strategy applicable to various diseases characterized by oxidative stress and inflammation.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFF0708700)
- Shanghai Municipal Health Commission (20224Z0002)
- National Natural Science Foundation of China (81971598)
- Shanghai Municipality (21XD1420900)
This publication has 70 references indexed in Scilit:
- MRI-visible mesoporous polydopamine nanoparticles with enhanced antioxidant capacity for osteoarthritis therapyBiomaterials, 2023
- Highly Bright AIE Nanoparticles by Regulating the Substituent of Rhodanine for Precise Early Detection of Atherosclerosis and Drug ScreeningAdvanced Materials, 2021
- miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseasesAgeing Research Reviews, 2021
- Recent advances in nanomaterials for therapy and diagnosis for atherosclerosisAdvanced Drug Delivery Reviews, 2021
- Cembrane-type diterpenoids from the South China Sea soft coral Sarcophyton mililatensisActa Pharmaceutica Sinica B, 2018
- Immobilization of Pt Nanoparticles via Rapid and Reusable Electropolymerization of Dopamine on TiO2 Nanotube Arrays for Reversible SERS Substrates and Nonenzymatic Glucose SensorsSmall, 2017
- Direct Insulation‐to‐Conduction Transformation of Adhesive Catecholamine for Simultaneous Increases of Electrical Conductivity and Mechanical Strength of CNT FibersAdvanced Materials, 2015
- Polyvalent Immunostimulatory Nanoagents with Self‐Assembled CpG Oligonucleotide‐Conjugated Gold NanoparticlesAngewandte Chemie International Edition, 2011
- Nucleic Acid–Gold Nanoparticle Conjugates as Mimics of microRNASmall, 2011
- MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteinsArthritis & Rheumatism, 2009